Assessment of BMS-986094-induced chronic cardiotoxicity using human iPS cell-derived cardiomyocytes

被引：0
|
作者：
Yanagida, Shota [1 ,2 ]
Satsuka, Ayano [1 ]
Hayashi, Sayo [1 ]
Ono, Atsushi [2 ]
Kanda, Yasunari [1 ]
机构：
[1] Natl Inst Hlth Sci, Div Pharmacol, Kawasaki, Kanagawa, Japan
[2] Okayama Univ, Graduated Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama, Okayama, Japan
来源：
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 2023年 / 123卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SP104
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update
    Kanda, Yasunari
    Yamazaki, Daiju
    Osada, Tomoharu
    Yoshinaga, Takashi
    Sawada, Kohei
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 138 (04) : 233 - 239
  • [42] Effects of a drug on the repolarization phase in cardiomyocytes - assessment using an iPS cell-derived cardiomyocyte sheet
    Matsuo, Junko
    Miyamoto, Norimasa
    Ojima, Atsuko
    Kanda, Yasunari
    Sawada, Kohei
    Arimura, Yukiko
    Suzuki, Akiko
    Yoshifuku, Tomoko
    Sekino, Yuko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S81 - S81
  • [43] Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Yiqi Gong
    Li Yang
    Jun Tang
    Jijian Zheng
    Nevin Witman
    Philipp Jakob
    Yao Tan
    Minglu Liu
    Ying Chen
    Huijing Wang
    Wei Fu
    Wei Wang
    Cardiovascular Toxicology, 2022, 22 : 141 - 151
  • [44] The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands
    Freund, C.
    Davis, R. P.
    Gkatzis, K.
    Ward-van Oostwaard, D.
    Mummery, C. L.
    NETHERLANDS HEART JOURNAL, 2010, 18 (01) : 51 - 54
  • [45] Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Gong, Yiqi
    Yang, Li
    Tang, Jun
    Zheng, Jijian
    Witman, Nevin
    Jakob, Philipp
    Tan, Yao
    Liu, Minglu
    Chen, Ying
    Wang, Huijing
    Fu, Wei
    Wang, Wei
    CARDIOVASCULAR TOXICOLOGY, 2022, 22 (02) : 141 - 151
  • [46] Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes
    Kim, Ye Seul
    Lee, Soo Yong
    Yoon, Jung Won
    Kim, Dasol
    Yu, Sangbin
    Kim, Jeong Su
    Kim, Jae Ho
    BMB REPORTS, 2020, 53 (10) : 545 - 550
  • [47] Cardiotoxicity of chemotherapeutic agents assessed in human embryonic or induced pluripotent stem cell-derived cardiomyocytes
    Mioulane, M.
    Foldes, G.
    Harding, S. E.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S47 - S47
  • [48] Retention of locally injected human iPS cell-derived cardiomyocytes into the myocardium using hydrolyzed gelatin
    Iida, Jun
    Kotani, Kazuki
    Murata, Kozue
    Hakamada, Keisuke
    Maihemuti, Wusiman
    Mandai, Yoshinobu
    Hiraoka, Yosuke
    Minatoya, Kenji
    Masumoto, Hidetoshi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [49] Preventing Anthracycline-Induced Cardiotoxicity Using Functional Genomics and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Lo Sardo, Valentina
    Kamp, Timothy J.
    CIRCULATION, 2022, 145 (04) : 295 - 298
  • [50] Bridging functional and structural cardiotoxicity assays using human stem cell-derived cardiomyocytes for a more comprehensive risk assessment
    Clements, Mike
    Millar, Val
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2016, 81 : 340 - 341
12345